3.8 Article

Missed acute myocardial infarction in the emergency department-standardizing measurement of misdiagnosis-related harms using the SPADE method

Journal

DIAGNOSIS
Volume 8, Issue 2, Pages 177-186

Publisher

WALTER DE GRUYTER GMBH
DOI: 10.1515/dx-2020-0049

Keywords

chest pain; diagnostic errors; dyspnea; emergency medical services; healthcare disparities; health services research; myocardial infarction

Funding

  1. Gordon & Betty Moore Foundation [GBMF5756]
  2. Armstrong Institute Center for Diagnostic Excellence at the Johns Hopkins University School of Medicine

Ask authors/readers for more resources

The SPADE method accurately quantifies misdiagnosis-related harms from missed AMIs, showing that there were 574 probable missed AMIs resulting in hospitalization within 30 days at a rate of 1.3% per AMI. However, the adverse event rate per symptom discharge for chest pain or dyspnea in the ED was only 0.2%.
Objectives: Diagnostic error is a serious public health problem. Measuring diagnostic performance remains elusive. We sought to measure misdiagnosis-related harms following missed acute myocardial infarctions (AMI) in the emergency department (ED) using the symptom-disease pair analysis of diagnostic error (SPADE) method. Methods: Retrospective administrative data analysis (2009-2017) from a single, integrated health system using International Classification of Diseases (ICD) coded discharge diagnoses. We looked back 30 days from AMI hospitalizations for antecedent ED treat-and-release visits to identify symptoms linked to probable missed AMI (observed > expected). We then looked forward from these ED discharge diagnoses to identify symptom-disease pair misdiagnosis-related harms (AMI hospitalizations within 30-days, representing diagnostic adverse events). Results: A total of 44,473 AMI hospitalizations were associated with 2,874 treat-and-release ED visits in the prior 30 days. The top plausibly-related ED discharge diagnoses were chest pain and dyspnea with excess treat-and-release visit rates of 9.8% (95% CI 8.5-11.2%) and 3.4% (95% CI 2.7-4.2%), respectively. These represented 574 probable missed AMIs resulting in hospitalization (adverse event rate per AMI 1.3%, 95% CI 1.2-1.4%). Looking forward, 325,088 chest pain or dyspnea ED discharges were followed by 508 AMI hospitalizations (adverse event rate per symptom discharge 0.2%, 95% CI 0.1-0.2%). Conclusions: The SPADE method precisely quantifies misdiagnosis-related harms from missed AMIs using administrative data. This approach could facilitate future assessment of diagnostic performance across health systems. These results correspond to similar to 10,000 potentially-preventable harms annually in the US. However, relatively low error and adverse event rates may pose challenges to reducing harms for this ED symptom-disease pair.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available